Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494792 · ClinicalTrials.gov registry record
Sofia Strep A FIA Field Study
A clinical trial, sponsored by Quidel Corporation.
- Terminated
- Registry status
- 2,090
- Enrollment target
NCT01494792: Clinical Trial study, sponsored by Quidel Corporation.
NCT01494792 is a clinical trial that was terminated before completion, run by Quidel Corporation. The registered enrollment target is 2,090 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01494792 was terminated before completion, sponsored by Quidel Corporation.
- TERMINATED
- Registry status
- 2,090 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.
Interventions
- DEVICE In Vitro Diagnositc aid for diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,090 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-08 |
Why NCT01494792 stopped before completion
NCT01494792 is an observational study that tracks outcomes without assigning an intervention. Its 2,090 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which In Vitro Diagnositc aid for diagnosis is the first listed.
NCT01494792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01494792 about?
NCT01494792 is a clinical study titled "Sofia Strep A FIA Field Study". The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.
What is the current status of trial NCT01494792?
This trial is currently terminated. The enrollment target is 2,090 participants. The study started on 2011-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01494792?
The interventions under investigation include: In Vitro Diagnositc aid for diagnosis (DEVICE).
Who is sponsoring clinical trial NCT01494792?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06324981 · 2,100 participants · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia